Detalhe da pesquisa
1.
HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage.
Immunity
; 47(5): 990-1003.e9, 2017 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29166592
2.
Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers.
Immunity
; 40(5): 657-68, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24768347
3.
Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.
J Virol
; 91(3)2017 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27852851
4.
Broad neutralization coverage of HIV by multiple highly potent antibodies.
Nature
; 477(7365): 466-70, 2011 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-21849977
5.
The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies.
PLoS Pathog
; 9(11): e1003754, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24278016
6.
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo.
Proc Natl Acad Sci U S A
; 109(46): 18921-5, 2012 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23100539
7.
Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses.
Proc Natl Acad Sci U S A
; 107(28): 12658-63, 2010 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-20615945
8.
Immunological considerations for developing antibody therapeutics for Influenza A.
Hum Vaccin Immunother
; 12(2): 474-7, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26325257
9.
Efficacy of broadly neutralizing monoclonal antibody PG16 in HIV-infected humanized mice.
Virology
; 462-463: 115-25, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24971704
10.
From PGx to molecular diagnostics and personalized medicine.
Drug Discov Today
; 8(18): 829-31, 2003 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12963318
11.
Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target.
Science
; 326(5950): 285-9, 2009 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-19729618